We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ZBIO market cap is 418.83M. The company's latest EPS is USD -3.7558 and P/E is -2.67.
| Quarter End | Sep 2024 | Dec 2024 | |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 5M | |
| Operating Income | -40.99M | -55.62M | |
| Net Income | -38.61M | -52.6M |
| Year End 31 December 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 50M | 5M |
| Operating Income | -76.2M | -37.15M | -163.89M |
| Net Income | -119.28M | -37.12M | -156.99M |
| Quarter End | Sep 2024 | Dec 2024 | |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 403.43M | 369.97M | |
| Total Liabilities | 44M | 57.51M | |
| Total Equity | 359.44M | 312.46M |
| Year End 31 December 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 74.58M | 68.18M | 369.97M |
| Total Liabilities | 26.78M | 43.82M | 57.51M |
| Total Equity | -192.29M | -225.72M | 312.46M |
| Quarter End | Sep 2024 | Dec 2024 | |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -81.12M | -119.67M | |
| Investing | -26.82M | -30.55M | |
| Financing | 411.11M | 412.96M |
| Year End 31 December 2024 | 2022 | 2023 | 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -65.65M | -30.53M | -119.67M |
| Investing | -2.2M | -17k | -30.55M |
| Financing | 59.39M | 20.12M | 412.96M |
| Market Cap | 418.83M |
| Price to Earnings Ratio | -2.67 |
| Price to Sales Ratio | 83.78 |
| Price to Cash Ratio | 1.31 |
| Price to Book Ratio | 1.34 |
| Dividend Yield | - |
| Shares Outstanding | 41.8M |
| Average Volume (1 week) | 177.32k |
| Average Volume (1 Month) | 224.35k |
| 52 Week Change | -0.00% |
| 52 Week High | 26.11 |
| 52 Week Low | 5.83 |
| Spread (Intraday) | 1.48 (13.75%) |
| Company Name | Zenas BioPharma Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
